Published in Am J Hematol on May 01, 2010
Prekallikrein deficiency presenting as recurrent cerebrovascular accident: case report and review of the literature. Case Rep Hematol (2012) 0.75
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med (2002) 3.51
An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood (2002) 1.78
Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: a critical evaluation. Am J Hematol (2008) 1.48
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. Thromb Haemost (2003) 1.46
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified. J Thromb Thrombolysis (2009) 1.38
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood (2002) 1.23
Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost (2006) 1.12
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab (2002) 1.10
Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia. Clin Chem Lab Med (2015) 1.06
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood (2002) 1.02
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ (2004) 0.96
C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost (2006) 0.95
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. Blood (2002) 0.93
The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost (2002) 0.93
Rebuttal: factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed. Thromb Haemost (2004) 0.92
Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med (2002) 0.89
Congenital prekallikrein deficiency. Expert Rev Hematol (2010) 0.86
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. Haematologica (2003) 0.86
The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost (2003) 0.84
Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis (2003) 0.84
Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost (2006) 0.83
Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. Haematologica (2005) 0.83
Results of case-control studies support the association between contact lens use and Acanthamoeba keratitis. Clin Ophthalmol (2013) 0.82
Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes). J Thromb Thrombolysis (2011) 0.82
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood (2002) 0.82
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost (2004) 0.82
Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis. Acta Haematol (2010) 0.82
Occurrence of thrombosis in congenital thrombocytopenic disorders: a critical annotation of the literature. Blood Coagul Fibrinolysis (2013) 0.81
Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis (2008) 0.81
Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. Blood Coagul Fibrinolysis (2009) 0.81
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood (2002) 0.81
Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost (2005) 0.81
Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost (2003) 0.79
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. Acta Haematol (2006) 0.79
The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency. J Thromb Thrombolysis (2010) 0.79
Epidemiology of primary and secondary thrombocytopenia: first analysis of an administrative database in a major Italian institution. Blood Coagul Fibrinolysis (2012) 0.79
The lack of ties between north-eastern Italy and African-Americans suggest a multi-founder effect for FVII Padua (Arg304Gln) disorder. Blood Coagul Fibrinolysis (2010) 0.78
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. Clin Appl Thromb Hemost (2007) 0.78
A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding. Platelets (2008) 0.78
Influence of the Alu-repeat I/D polymorphism in t-PA gene intron 8 on the stimulated t-PA release after venous occlusion. Clin Appl Thromb Hemost (2003) 0.78
FXII deficiency is neither a cause of thrombosis nor a protection from thrombosis. Am J Ophthalmol (2005) 0.78
Different genotypes are responsible for the normal Russell viper venom assays seen in some cases of congenital factor X deficiency. Am J Hematol (2008) 0.77
Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy. Transplantation (2003) 0.77
Congenital FVII deficiency and thrombotic events after replacement therapy. J Thromb Thrombolysis (2011) 0.77
Efficacy of AT in pre-eclampsia: a case-control prospective trial. Thromb Haemost (2004) 0.77
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. Thromb Res (2010) 0.76
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. Blood Coagul Fibrinolysis (2014) 0.76
p53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy. Anticancer Res (2003) 0.76
Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost (2002) 0.76
The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)". Semin Thromb Hemost (2010) 0.75
Mutations are no substitutes for clotting, chromogenic and immunological assays in patients with congenital prothrombin deficiency. Am J Hematol (2008) 0.75
Oral contraceptives, thrombosis and socio-ethical values: an inevitable compromise is needed based mainly on a careful evaluation of potential users. Clin Appl Thromb Hemost (2005) 0.75
A comment about the correct attribution of the discovery of FX Friuli disorder. Clin Appl Thromb Hemost (2012) 0.75
Selection of both normal and bleeding patients is indicated before desmopressin administration. Thromb Haemost (2005) 0.75
The spectrum of factor VII deficiencies and abnormalities. Blood Coagul Fibrinolysis (2004) 0.75
Considerations on a tentative classification of FVII deficiency suited for practical clinical purposes. Clin Appl Thromb Hemost (2012) 0.75
Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias. Hematology (2012) 0.75
A large deletion due to a new mutation (intron 13/exon 23) in a sporadic case of severe hemophilia A. Clin Appl Thromb Hemost (2004) 0.75
Conformation sensitive gel electrophoresis for detection of factor X gene mutations. Thromb Res (2002) 0.75
Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia. Haematologica (2002) 0.75
Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis. Haematologica (2002) 0.75
Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate. Thromb Res (2002) 0.75
Difficulties in the mutation analysis of plasminogen gene: a study in two patients with ligneous conjunctivitis. Clin Appl Thromb Hemost (2006) 0.75
A new mutation (Arg251Trp) in the Ca2+ binding site of factor X protease domain appears to be responsible for the defect in the extrinsic pathway activation of factor X Padua. Clin Appl Thromb Hemost (2004) 0.75
Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many. Blood Coagul Fibrinolysis (2009) 0.75
Recent progress in the therapeutic management of pre-eclampsia. Expert Opin Pharmacother (2004) 0.75
Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke? J Thromb Thrombolysis (2007) 0.75
[Perioperative control of vitamin K antagonists in elective surgery]. Medicina (B Aires) (2014) 0.75
Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). Haematologica (2002) 0.75
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. Eur J Haematol (2011) 0.75
Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues. Hematology (2013) 0.75
Thrombocytosis and recurrent hepatic outflow obstruction (Budd-Chiari syndrome) after successful thrombolysis: case report and literature review. Clin Appl Thromb Hemost (2002) 0.75
Confirmation of the value of a modified long-distance polymerase chain reaction in the detection of inversion intron 22 in severe hemophilia a: a technical note. Clin Appl Thromb Hemost (2005) 0.75
Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency. Eur J Haematol (2013) 0.75
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors. Thromb Haemost (2003) 0.75
Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders. Thromb Haemost (2007) 0.75
The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain. Hematology (2009) 0.75
A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain. Blood Coagul Fibrinolysis (2003) 0.75
A cluster of factor XI-deficient patients due to a new mutation (Ile 436 Lys) in northeastern Italy. Eur J Haematol (2011) 0.75